ExodusPoint Capital Management, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,060
-99.9%
423,898
+2.5%
0.02%
-34.8%
Q3 2022$1,745,000
+372.9%
413,612
+212.7%
0.02%
+360.0%
Q2 2022$369,000
-61.5%
132,253
-21.0%
0.01%
-58.3%
Q1 2022$958,000
+55.5%
167,502
+148.3%
0.01%
+100.0%
Q4 2021$616,000
+42.6%
67,463
+153.4%
0.01%0.0%
Q1 2021$432,000
-53.1%
26,627
-57.2%
0.01%
-66.7%
Q3 2020$922,000
-10.3%
62,210
-11.0%
0.02%
-33.3%
Q2 2020$1,028,00069,9060.03%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TANG KEVIN 18,158$269,00021.76%
TANG CAPITAL MANAGEMENT LLC 2,896,904$42,932,0007.77%
Consonance Capital Management LP 2,005,218$29,717,0003.62%
NEXPOINT ASSET MANAGEMENT, L.P. 721,064$10,686,0002.42%
Congress Park Capital LLC 204,849$3,036,0001.88%
Pekin Hardy Strauss, Inc. 594,913$8,817,0001.80%
PFM Health Sciences, LP 1,872,012$27,743,0001.28%
XTX MARKETS LLC 11,575$172,0000.83%
ArrowMark Colorado Holdings LLC 5,059,526$74,982,0000.72%
DSAM Partners (London) Ltd 261,306$3,873,0000.67%
View complete list of HERON THERAPEUTICS INC shareholders